Skip to content

Clinical trials

Phase 1/2 Myeloproliferative Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Phase: Phase 1/2 Clear all

63 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20011
20023
20033
20041
20053
20061
20071
20083
20091
20102
20111
20122
20133
20143
20153
20163
20172
20183
20193
20202
20212
20223
20243
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed36
Terminated8
Withdrawn7
Recruiting6
Active, not recruiting5
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center7
M.D. Anderson Cancer Center7
Incyte Corporation4
Masonic Cancer Center, University of Minnesota3
Baylor College of Medicine2
National Cancer Institute (NCI)2
AbbVie1
Alliance for Clinical Trials in Oncology1
Ariad Pharmaceuticals1
Asan Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders63
Myelodysplastic Syndromes38
Leukemia, Myeloid, Acute31
Primary Myelofibrosis29
Leukemia24
Leukemia, Myelomonocytic, Chronic22
Precursor Cell Lymphoblastic Leukemia-Lymphoma22
Multiple Myeloma21
Lymphoma, Non-Hodgkin20
Thrombocythemia, Essential20

Trials

Showing 1 to 25 of 63. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.